Suppressive Effect of Antibiotic Siomycin on Antibody Production

The antibiotic thiazole compound siomycin, which we have found from the culture broth of Actinomycetes (strain No. 806097) in search of antibody production inhibitor, showed the in vitro immunosuppressive property against B-cells stimulated with T-cell independent antigen DNP-LPS (dinitrophenyl-lipo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of antibiotics 2004/09/25, Vol.57(9), pp.590-596
Hauptverfasser: UENO, MOTOI, FURUKAWA, SATOKO, ABE, FUMIE, USHIODA, MICHIKO, FUJINE, KIYOTAKA, JOHKI, SHIGERU, HATORI, HIDETAKA, UEDA, HIROTSUGU
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 596
container_issue 9
container_start_page 590
container_title Journal of antibiotics
container_volume 57
creator UENO, MOTOI
FURUKAWA, SATOKO
ABE, FUMIE
USHIODA, MICHIKO
FUJINE, KIYOTAKA
JOHKI, SHIGERU
HATORI, HIDETAKA
UEDA, HIROTSUGU
description The antibiotic thiazole compound siomycin, which we have found from the culture broth of Actinomycetes (strain No. 806097) in search of antibody production inhibitor, showed the in vitro immunosuppressive property against B-cells stimulated with T-cell independent antigen DNP-LPS (dinitrophenyl-lipopolysaccharide) while it also showed inhibitory effect against T-cell proliferation. Its inhibitory mechanism was considered to be different from that of FK506, the representative of T-cell immunosuppressant. Moreover, siomycin showed inhibitory effect in both T-cell dependent and independent murine antibody production models and decreased the severity in murine collagen arthritis model. Therefore, siomycin is a unique immunosuppressant which has potential for the treatment of some antibody-mediated diseases.
doi_str_mv 10.7164/antibiotics.57.590
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67141779</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17700111</sourcerecordid><originalsourceid>FETCH-LOGICAL-c633t-3b688417f867b89f5726c2c9854535c45bb48d29635e386833745fde485b12343</originalsourceid><addsrcrecordid>eNqFkMtKw0AUQAdRbK3-gAvJyl3qTOa9s5T6wIJCdT0kk4lOSTJxJhH696Yk1O7c3AuXc8_iAHCN4JwjRu7SurWZda3VYU75nEp4AqZICBQjwuQpmEKYoFiIBE7ARQhbCDHHXJyDCaJUQMngFNxvuqbxJgT7Y6JVURjdRq6IFgd1tLGu2mlbR64ezi7fRW_e5Z1urasvwVmRlsFcjXsGPh5W78uneP36-LxcrGPNMG5jnDEhCOKFYDwTsqA8YTrRUlBCMdWEZhkReSIZpgYLJjDmhBa5IYJmKMEEz8Dt4G28--5MaFVlgzZlmdbGdUExjno9l_-CPQQhQqgHkwHU3oXgTaEab6vU7xSCah9YHQVWlKs-cP90M9q7rDL538tYtAdeBmAb2vTTHIDU95rSHDuRZGLvleOQ8EDpr9QrU-NfKe2Txg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17700111</pqid></control><display><type>article</type><title>Suppressive Effect of Antibiotic Siomycin on Antibody Production</title><source>J-STAGE Free</source><source>MEDLINE</source><creator>UENO, MOTOI ; FURUKAWA, SATOKO ; ABE, FUMIE ; USHIODA, MICHIKO ; FUJINE, KIYOTAKA ; JOHKI, SHIGERU ; HATORI, HIDETAKA ; UEDA, HIROTSUGU</creator><creatorcontrib>UENO, MOTOI ; FURUKAWA, SATOKO ; ABE, FUMIE ; USHIODA, MICHIKO ; FUJINE, KIYOTAKA ; JOHKI, SHIGERU ; HATORI, HIDETAKA ; UEDA, HIROTSUGU</creatorcontrib><description>The antibiotic thiazole compound siomycin, which we have found from the culture broth of Actinomycetes (strain No. 806097) in search of antibody production inhibitor, showed the in vitro immunosuppressive property against B-cells stimulated with T-cell independent antigen DNP-LPS (dinitrophenyl-lipopolysaccharide) while it also showed inhibitory effect against T-cell proliferation. Its inhibitory mechanism was considered to be different from that of FK506, the representative of T-cell immunosuppressant. Moreover, siomycin showed inhibitory effect in both T-cell dependent and independent murine antibody production models and decreased the severity in murine collagen arthritis model. Therefore, siomycin is a unique immunosuppressant which has potential for the treatment of some antibody-mediated diseases.</description><identifier>ISSN: 0021-8820</identifier><identifier>EISSN: 1881-1469</identifier><identifier>DOI: 10.7164/antibiotics.57.590</identifier><identifier>PMID: 15580960</identifier><language>eng</language><publisher>Japan: JAPAN ANTIBIOTICS RESEARCH ASSOCIATION</publisher><subject>Animals ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Antibody Formation - drug effects ; Arthritis, Experimental - drug therapy ; B-Lymphocytes - immunology ; Collagen ; Female ; Humans ; Immunosuppressive Agents - pharmacology ; Immunosuppressive Agents - therapeutic use ; Lymphocyte Activation - drug effects ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Inbred DBA ; Peptides - pharmacology ; Peptides - therapeutic use ; T-Lymphocytes - immunology ; Tacrolimus - pharmacology ; Tacrolimus - therapeutic use ; Thiostrepton - pharmacology ; Thiostrepton - therapeutic use</subject><ispartof>The Journal of Antibiotics, 2004/09/25, Vol.57(9), pp.590-596</ispartof><rights>Japan Antibiotics Research Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c633t-3b688417f867b89f5726c2c9854535c45bb48d29635e386833745fde485b12343</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15580960$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>UENO, MOTOI</creatorcontrib><creatorcontrib>FURUKAWA, SATOKO</creatorcontrib><creatorcontrib>ABE, FUMIE</creatorcontrib><creatorcontrib>USHIODA, MICHIKO</creatorcontrib><creatorcontrib>FUJINE, KIYOTAKA</creatorcontrib><creatorcontrib>JOHKI, SHIGERU</creatorcontrib><creatorcontrib>HATORI, HIDETAKA</creatorcontrib><creatorcontrib>UEDA, HIROTSUGU</creatorcontrib><title>Suppressive Effect of Antibiotic Siomycin on Antibody Production</title><title>Journal of antibiotics</title><addtitle>J. Antibiot.</addtitle><description>The antibiotic thiazole compound siomycin, which we have found from the culture broth of Actinomycetes (strain No. 806097) in search of antibody production inhibitor, showed the in vitro immunosuppressive property against B-cells stimulated with T-cell independent antigen DNP-LPS (dinitrophenyl-lipopolysaccharide) while it also showed inhibitory effect against T-cell proliferation. Its inhibitory mechanism was considered to be different from that of FK506, the representative of T-cell immunosuppressant. Moreover, siomycin showed inhibitory effect in both T-cell dependent and independent murine antibody production models and decreased the severity in murine collagen arthritis model. Therefore, siomycin is a unique immunosuppressant which has potential for the treatment of some antibody-mediated diseases.</description><subject>Animals</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibody Formation - drug effects</subject><subject>Arthritis, Experimental - drug therapy</subject><subject>B-Lymphocytes - immunology</subject><subject>Collagen</subject><subject>Female</subject><subject>Humans</subject><subject>Immunosuppressive Agents - pharmacology</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Lymphocyte Activation - drug effects</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Inbred DBA</subject><subject>Peptides - pharmacology</subject><subject>Peptides - therapeutic use</subject><subject>T-Lymphocytes - immunology</subject><subject>Tacrolimus - pharmacology</subject><subject>Tacrolimus - therapeutic use</subject><subject>Thiostrepton - pharmacology</subject><subject>Thiostrepton - therapeutic use</subject><issn>0021-8820</issn><issn>1881-1469</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtKw0AUQAdRbK3-gAvJyl3qTOa9s5T6wIJCdT0kk4lOSTJxJhH696Yk1O7c3AuXc8_iAHCN4JwjRu7SurWZda3VYU75nEp4AqZICBQjwuQpmEKYoFiIBE7ARQhbCDHHXJyDCaJUQMngFNxvuqbxJgT7Y6JVURjdRq6IFgd1tLGu2mlbR64ezi7fRW_e5Z1urasvwVmRlsFcjXsGPh5W78uneP36-LxcrGPNMG5jnDEhCOKFYDwTsqA8YTrRUlBCMdWEZhkReSIZpgYLJjDmhBa5IYJmKMEEz8Dt4G28--5MaFVlgzZlmdbGdUExjno9l_-CPQQhQqgHkwHU3oXgTaEab6vU7xSCah9YHQVWlKs-cP90M9q7rDL538tYtAdeBmAb2vTTHIDU95rSHDuRZGLvleOQ8EDpr9QrU-NfKe2Txg</recordid><startdate>2004</startdate><enddate>2004</enddate><creator>UENO, MOTOI</creator><creator>FURUKAWA, SATOKO</creator><creator>ABE, FUMIE</creator><creator>USHIODA, MICHIKO</creator><creator>FUJINE, KIYOTAKA</creator><creator>JOHKI, SHIGERU</creator><creator>HATORI, HIDETAKA</creator><creator>UEDA, HIROTSUGU</creator><general>JAPAN ANTIBIOTICS RESEARCH ASSOCIATION</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>2004</creationdate><title>Suppressive Effect of Antibiotic Siomycin on Antibody Production</title><author>UENO, MOTOI ; FURUKAWA, SATOKO ; ABE, FUMIE ; USHIODA, MICHIKO ; FUJINE, KIYOTAKA ; JOHKI, SHIGERU ; HATORI, HIDETAKA ; UEDA, HIROTSUGU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c633t-3b688417f867b89f5726c2c9854535c45bb48d29635e386833745fde485b12343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibody Formation - drug effects</topic><topic>Arthritis, Experimental - drug therapy</topic><topic>B-Lymphocytes - immunology</topic><topic>Collagen</topic><topic>Female</topic><topic>Humans</topic><topic>Immunosuppressive Agents - pharmacology</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Lymphocyte Activation - drug effects</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Inbred DBA</topic><topic>Peptides - pharmacology</topic><topic>Peptides - therapeutic use</topic><topic>T-Lymphocytes - immunology</topic><topic>Tacrolimus - pharmacology</topic><topic>Tacrolimus - therapeutic use</topic><topic>Thiostrepton - pharmacology</topic><topic>Thiostrepton - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>UENO, MOTOI</creatorcontrib><creatorcontrib>FURUKAWA, SATOKO</creatorcontrib><creatorcontrib>ABE, FUMIE</creatorcontrib><creatorcontrib>USHIODA, MICHIKO</creatorcontrib><creatorcontrib>FUJINE, KIYOTAKA</creatorcontrib><creatorcontrib>JOHKI, SHIGERU</creatorcontrib><creatorcontrib>HATORI, HIDETAKA</creatorcontrib><creatorcontrib>UEDA, HIROTSUGU</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of antibiotics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>UENO, MOTOI</au><au>FURUKAWA, SATOKO</au><au>ABE, FUMIE</au><au>USHIODA, MICHIKO</au><au>FUJINE, KIYOTAKA</au><au>JOHKI, SHIGERU</au><au>HATORI, HIDETAKA</au><au>UEDA, HIROTSUGU</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Suppressive Effect of Antibiotic Siomycin on Antibody Production</atitle><jtitle>Journal of antibiotics</jtitle><addtitle>J. Antibiot.</addtitle><date>2004</date><risdate>2004</risdate><volume>57</volume><issue>9</issue><spage>590</spage><epage>596</epage><pages>590-596</pages><issn>0021-8820</issn><eissn>1881-1469</eissn><abstract>The antibiotic thiazole compound siomycin, which we have found from the culture broth of Actinomycetes (strain No. 806097) in search of antibody production inhibitor, showed the in vitro immunosuppressive property against B-cells stimulated with T-cell independent antigen DNP-LPS (dinitrophenyl-lipopolysaccharide) while it also showed inhibitory effect against T-cell proliferation. Its inhibitory mechanism was considered to be different from that of FK506, the representative of T-cell immunosuppressant. Moreover, siomycin showed inhibitory effect in both T-cell dependent and independent murine antibody production models and decreased the severity in murine collagen arthritis model. Therefore, siomycin is a unique immunosuppressant which has potential for the treatment of some antibody-mediated diseases.</abstract><cop>Japan</cop><pub>JAPAN ANTIBIOTICS RESEARCH ASSOCIATION</pub><pmid>15580960</pmid><doi>10.7164/antibiotics.57.590</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-8820
ispartof The Journal of Antibiotics, 2004/09/25, Vol.57(9), pp.590-596
issn 0021-8820
1881-1469
language eng
recordid cdi_proquest_miscellaneous_67141779
source J-STAGE Free; MEDLINE
subjects Animals
Anti-Bacterial Agents - pharmacology
Anti-Bacterial Agents - therapeutic use
Antibody Formation - drug effects
Arthritis, Experimental - drug therapy
B-Lymphocytes - immunology
Collagen
Female
Humans
Immunosuppressive Agents - pharmacology
Immunosuppressive Agents - therapeutic use
Lymphocyte Activation - drug effects
Male
Mice
Mice, Inbred BALB C
Mice, Inbred DBA
Peptides - pharmacology
Peptides - therapeutic use
T-Lymphocytes - immunology
Tacrolimus - pharmacology
Tacrolimus - therapeutic use
Thiostrepton - pharmacology
Thiostrepton - therapeutic use
title Suppressive Effect of Antibiotic Siomycin on Antibody Production
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T02%3A55%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Suppressive%20Effect%20of%20Antibiotic%20Siomycin%20on%20Antibody%20Production&rft.jtitle=Journal%20of%20antibiotics&rft.au=UENO,%20MOTOI&rft.date=2004&rft.volume=57&rft.issue=9&rft.spage=590&rft.epage=596&rft.pages=590-596&rft.issn=0021-8820&rft.eissn=1881-1469&rft_id=info:doi/10.7164/antibiotics.57.590&rft_dat=%3Cproquest_cross%3E17700111%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17700111&rft_id=info:pmid/15580960&rfr_iscdi=true